Macrogol Aurobindo

Macrogol 4000, the active ingredient in Macrogol Aurobindo, is an osmotic laxative presented as an oral dosage form for oral use. It is employed to relieve constipation and to prepare the bowel for diagnostic procedures in adult and pediatric patients.

GNH USA supplies Macrogol Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable distribution across multiple regions. Products are manufactured under strict GMP conditions to ensure consistency and safety for end‑users.

Macrogol 4000 is used as an osmotic laxative to manage conditions affecting bowel function.

- Constipation: softens stool and increases bowel movements, providing relief in functional constipation. - Bowel preparation: clears the intestinal tract before colonoscopy or surgical procedures. - Chronic idiopathic constipation: maintains regularity in patients with long‑term constipation.

Macrogol 4000 may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas leading to discomfort. - Nausea: feeling of unease or urge to vomit. - Diarrhea: loose, watery stools occurring more frequently. - Abdominal cramps: intermittent pain or cramping in the stomach area. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal levels of sodium, potassium, or other electrolytes. - Severe dehydration: marked loss of body fluids requiring medical attention. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Rectal bleeding: presence of blood in stool or on toilet paper. - Severe abdominal pain: intense, persistent pain that may indicate complications.

When prescribing Macrogol 4000, clinicians should consider several safety measures.

- Renal function assessment: evaluate kidney function before initiating therapy. - Electrolyte monitoring: check serum electrolytes in patients at risk of imbalance. - Bowel obstruction caution: avoid use in individuals with known or suspected intestinal blockage. - Hypersensitivity screening: discontinue if signs of allergic reaction appear. - Dose adjustment in the elderly: start with the lowest effective dose and monitor response. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Macrogol 4000 can affect the absorption of other orally administered medicines.

Major Interactions (Avoid): - Antacids: may reduce the laxative's effectiveness by altering gastric pH. - Oral contraceptives: potential decrease in hormone absorption, risking reduced contraceptive efficacy. - Lithium: increased risk of lithium toxicity due to altered renal clearance.

Moderate Interactions (Monitor Closely): - Digoxin: possible reduction in absorption leading to sub‑therapeutic levels. - Tetracycline antibiotics: decreased bioavailability when taken concurrently. - Iron supplements: reduced iron absorption; separate dosing times are recommended.